388106-35-2

Upstream product

• 35710-17-9 2‐(4‐fluorobenzamido)benzohydrazide 
• 18600-51-6 2-(4-fluorophenyl)-4H-benzo[d][1,3]oxazin-4-one 
• 118-92-3 anthranilic acid 
• 403-43-0 4-fluorobenzoyl chloride 
• 18600-61-8 2-[(4-fluorobenzoyl)amino]benzoic acid 

Downstream Products

• 389576-52-7 3-(4-bromobenzylamino)-2-(4-fluorophenyl)quinazolin-4(3H)-one 
• 309925-98-2 4-bromo-N-[2-(4-fluoro-phenyl)-4-oxo-4H-quinazolin-3-yl]-benzamide 
• 1029982-40-8 3-((4-bromobenzyl)(ethyl)amino)-2-(4-fluorophenyl)quinazolin-4(3H)-one 

Relevant academic research and scientific papers

Quinazolinone-schiff's base hybrids as phosphodiesterase 4b inhibitors with dual activity against COPD and lung cancer

A series of thirty compounds of quinazolinone-Schiff's base hybrids were rationally designed, synthesized, and evaluated for their in vitro Phosphodiesterase 4B inhibition, anti-lung and anti-colon cancer activities. Compounds 9, 16, 23, 29, 30, 31, 32 an

QUINAZOLINONE MODULATORS OF TGR5

The present invention relates to quinazolinone compounds useful as modulators of TGR5 and methods for the treatment or prevention of metabolic, cardiovascular, and inflammatory diseases.

QUINAZOLINONE MODULATORS OF TGR5

The present invention relates to quinazolinone compounds useful as modulators of TGR5 and methods for the treatment or prevention of metabolic, cardiovascular, and inflammatory diseases.